Biomarkers and epidemiology
111 – 120 of 159
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Menstrual Factors, Reproductive History, Hormone Use, and Urothelial Carcinoma Risk : A Prospective Study in the EPIC Cohort
(2020) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 29(8). p.1654-1664
- Contribution to journal › Article
-
Mark
Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
- Contribution to journal › Article
-
Mark
Desloratadine and loratadine stand out among common H1-antihistamines for association with improved breast cancer survival
- Contribution to journal › Article
-
Mark
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
- Contribution to journal › Letter
-
Mark
Added value of contrast-enhanced mammography (CEM) in staging of malignant breast lesions - A feasibility study
- Contribution to journal › Article
-
Mark
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk
- Contribution to journal › Article
-
Mark
Linear age-course effects on the associations between body mass index, triglycerides, and female breast and male liver cancer risk : An internal replication study of 800,000 individuals
- Contribution to journal › Article
-
Mark
Comprehensive transcriptomic profiling identifies breast cancer patients who may be spared adjuvant systemic therapy
- Contribution to journal › Article
-
Mark
Different domains of self-reported physical activity and risk of type 2 diabetes in a population-based Swedish cohort : the Malmö diet and Cancer study
- Contribution to journal › Article
-
Mark
Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer
- Contribution to journal › Article
